: Russias Sputnik V gets Emergency Use Authorisation nod in India #IndiaNEWS #Latest News NEW DELHI : Russias Sputnik V got approval from the Subject expert committee (SEC) for Emergency Use Authorisation

Russias Sputnik V gets Emergency Use Authorisation nod in India #IndiaNEWS #Latest News
NEW DELHI : Russias Sputnik V got approval from the Subject expert committee (SEC) for Emergency Use Authorisation (EUA), making it the third Covid-19 vaccine to get clearance in India.
According to sources, the SEC approved Dr Reddys application for EUA to Sputnik V.
The decision comes after the Drugs Controller General of India (DCGI)s SEC met today to take up Sputnik V application for EUA in India.
Dr Reddys Laboratories, last week sought the governments approval for the vaccine to be used in India. The Russian Direct Investment Fund (RDIF) partnered with Dr Reddys in September 2020 to conduct clinical trials of Sputnik V in India.
DCGI had then sought additional data from drugmaker Dr Reddys Laboratories on its Sputnik V Covid-19 vaccine trial.
India is currently manufacturing two Covid-19 vaccines, Serum Institute of Indias locally-made Oxford Covid-19 vaccine Covishield and Bharat Biotechs indigenously manufactured Covaxin.
On Sunday, government sources said that by end of the third quarter of this year, India will be getting vaccines from five additional manufacturers.
The Russian vaccine has an effectiveness of 91.6 per cent. Russia registered Sputnik V for public use in August, the first country to do so, though the approval came before the start of the large-scale trial in September.
The EUA of Sputnik V comes at a time when India is facing the second wave of Covid-19 pandemic with the number of new cases increasing each day. (Agency)
The post Russias Sputnik V gets Emergency Use Authorisation nod in India appeared first on Jammu Kashmir Latest News | Tourism | Breaking News J&K.

Stock Market NEWS Best intraday tips Intraday Stocks below 100